Brawn Laboratories Limited Guaifenesin Export Data — India (DGFT 2022–2026)

Name: Brawn Laboratories Limited Guaifenesin Export Records India — #4 Exporter, 24 Shipments, $793.2K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Guaifenesin

India Pharmaceutical Trade Intelligence

$26.7M151 Suppliers77 CountriesHS 30049099

ExportsIndia → UNITED STATES69.6%India → IRAQ3.4%

#1 Supplier: GRANULES INDIA #1 Buyer: GRANULES CONSUMER

Brawn Laboratories Limited — Guaifenesin Exporter #4 | $793.2K Trade Value | TransData Nexus | TransData Nexus

Brawn Laboratories Limited — Guaifenesin Exporter Profile

Indian Pharmaceutical Exporter · #4 for Guaifenesin · $793.2K export value · DGFT Verified

Brawn Laboratories Limited is the #4 Indian exporter of Guaifenesin with $793.2K in export value and 24 verified shipments. Brawn Laboratories Limited holds a 3.0% market share in Guaifenesin exports across 2 countries. The company exports 17 pharmaceutical products worth $22.6M across 10 therapeutic categories.

Brawn Laboratories Limited — Guaifenesin Export Profile: Buyers & Destinations

Brawn Laboratories Limited Guaifenesin export treemap — buyers and destination countries | TransData Nexus

Where Does Brawn Laboratories Limited Export Guaifenesin?

Country	Value	Shipments	Share
IRAQ	$450.7K	22	92.9%
TURKEY	$34.3K	2	7.1%

Brawn Laboratories Limited exports Guaifenesin to 2 countries. The largest destination is IRAQ accounting for 92.9% of Brawn Laboratories Limited's Guaifenesin shipments. These destinations reflect Brawn Laboratories Limited's established distribution network and regulatory approvals in key markets.

Who Are the Top Buyers of Guaifenesin from Brawn Laboratories Limited?

Buyer

What Guaifenesin Formulations Does Brawn Laboratories Limited Export?

Product Description / Formulation	Value	Shipments
PARACETAMOL , PHENYLEPHRINE HYDROCHLORIDE AND GUAIFENESIN TABLETS EACH FILM COATED TABLET CONTAINS: PARACETAMOL BP*	$100.0K	2
EACH 5ML CONTS:CHLORPHENIRAMINE MALEATEUSP 1MG,GLYCERYL GUAIACOLATE 50MG ( GUAIFENESIN USP ), PHENYLEPHRINE *	$89.9K	6
EACH 5ML CONTS:CHLORPHENIRAMINE MALEATEUSP 1MG,GLYCERYL GUALACOLATE 50MG ( GUAIFENESIN USP ), PHENYLEPHRINE *	$89.8K	6
EACH 5ML CONTS:CHLORPHENIRAMINE MALEATEUSP 1MG,GLYCERYL GUAIACOLATE 50MG(GUAIFENESIN USP)PHENYLEPHRINE HYDROCHLORIDE*	$71.0K	6
PARACETAMOL , PHENYLEPHRINE HYDROCHLORIDE AND GUAIFENESIN TABLETS EACH UNCOATED BILAYERED TABLET CONTAINS: *	$50.0K	1
PARACETAMOL , PHENYLEPHRINE HYDROCHLORIDE AND GUAIFENESIN TABLETS EACH UNCOATED BILAYERED TABLET CONTAINS:*	$50.0K	1
EACH 5ML CONTS:CHLORPHENIRAMINE MALEATEUSP 1MG, GLYCERYL GUAIACOLATE 50MG (GUAIFENESIN USP ), PHENYLEPHRINE*	$27.3K	1
EACH 5ML CONTS:CHLORPHENIRAMINE MALEATEUSP 1MG,GLYCERYL GUALACOLATE 50MG ( GUAIFENESIN USP ), PHENYLEPHRINE*	$7.0K	1

Brawn Laboratories Limited exports 8 distinct Guaifenesin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is PARACETAMOL , PHENYLEPHRINE HYDROCHLORIDE AND GUAIFENESIN with 2 shipments worth $100.0K. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.

How Does Brawn Laboratories Limited Compare to Nearest Guaifenesin Exporters?

Exporters ranked immediately above and below #4 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
2	ELYSIUM PHARMACEUTICALS LTD	$3.9M	77	1	$50.0K
3	SUN PHARMACEUTICAL INDUSTRIES LIMITED	$899.7K	31	1	$29.0K
4	BRAWN LABORATORIES LIMITED ★	$793.2K	24	2	$33.1K
5	AGIO PHARMACEUTICALS LIMITED	$781.2K	34	3	$23.0K
7	EMCURE PHARMACEUTICALS LIMITED	$645.9K	46	11	$14.0K

Brawn Laboratories Limited ranks #4 among 151 Indian Guaifenesin exporters. Average shipment value of $33.1K compared to the market average of $131.8K. The closest competitors by value are ELYSIUM PHARMACEUTICALS LTD and SUN PHARMACEUTICAL INDUSTRIES LIMITED.

Which Indian Ports Ship Guaifenesin Exports?

Port	Shipments	% Share
HYDERABAD ICD	118	11.2%
NHAVA SHEVA SEA (INNSA1)	94	9.0%
JNPT	74	7.0%
JNPT/ NHAVA SHEVA SEA	70	6.7%
HYDERABAD AIR	53	5.0%
HYDERABAD ICD (INSNF6)	50	4.8%
MUNDRA SEA (INMUN1)	50	4.8%
MUNDRA SEA	47	4.5%

Geopolitical & Trade Policy Impact on Brawn Laboratories Limited's Guaifenesin Exports

Recent geopolitical developments have introduced significant challenges for Indian pharmaceutical exporters like Brawn Laboratories. The Israel-Iran tensions have escalated security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, leading to major carriers suspending or restricting transits. This has resulted in extended transit times by 10–20 days and a 40–50% increase in freight rates on key India–Europe routes, as reported by industry executives and insurers. (livemint.com)

In the United States, policy shifts towards reshoring pharmaceutical manufacturing and imposing tariffs on imports have prompted Indian companies to invest in U.S. facilities. This strategy aims to mitigate tariff impacts and secure market access. For instance, Indian firms have invested between $500-700 million in U.S. hubs during the partial fiscal year 2025-26, focusing on oncology and biologics. (odrindia.in) Such investments are crucial for maintaining competitiveness in the U.S. market amidst evolving trade policies.

The European Union's regulatory landscape is also evolving, with stringent compliance requirements under the Falsified Medicines Directive. Indian exporters must navigate these regulations to ensure market access, emphasizing the need for robust quality assurance and compliance frameworks. Brawn Laboratories' adherence to these standards is vital for sustaining and expanding its European market presence.

Brawn Laboratories Limited — Regulatory Compliance & Quality Standards

Compliance with international quality standards is paramount for Indian pharmaceutical exporters. The U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have intensified inspections and enforcement actions, necessitating stringent adherence to Good Manufacturing Practices (GMP). Instances of non-compliance have led to import bans and reputational damage for some Indian firms. (comcec.org) Therefore, Brawn Laboratories must prioritize quality control and regulatory compliance to maintain its export licenses and market credibility.

The Indian government's initiatives to bolster the pharmaceutical sector's compliance infrastructure, including the establishment of a dedicated 'CBAM Facilitation Cell' to assist exporters with complex reporting requirements, reflect a commitment to enhancing global competitiveness. (sgeexport.com) Brawn Laboratories' proactive engagement with these initiatives can further strengthen its compliance posture.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Guaifenesin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Brawn Laboratories Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 24 individual customs records matching Brawn Laboratories Limited exporting Guaifenesin, covering 8 formulations to 2 countries via 2 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 77+ countries, 278+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Guaifenesin

Guaifenesin

Brawn Laboratories Limited — Guaifenesin Exporter Profile

Brawn Laboratories Limited — Guaifenesin Export Profile: Buyers & Destinations

Where Does Brawn Laboratories Limited Export Guaifenesin?

Who Are the Top Buyers of Guaifenesin from Brawn Laboratories Limited?

What Is India's Total Guaifenesin Export Value and How Much Does Brawn Laboratories Limited Contribute?

What Is the Average Shipment Value for Brawn Laboratories Limited's Guaifenesin Exports?

How Does Brawn Laboratories Limited Compare to Other Indian Guaifenesin Exporters?

What Guaifenesin Formulations Does Brawn Laboratories Limited Export?

How Does Brawn Laboratories Limited Compare to Nearest Guaifenesin Exporters?

Which Indian Ports Ship Guaifenesin Exports?

What Other Respiratory & OTC Products Does Brawn Laboratories Limited Export?

Geopolitical & Trade Policy Impact on Brawn Laboratories Limited's Guaifenesin Exports

Brawn Laboratories Limited — Regulatory Compliance & Quality Standards

About Brawn Laboratories Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Guaifenesin Export Data from Brawn Laboratories Limited

Guaifenesin Stats

Company Overview

Top Products by Brawn Laboratories Limited

Related Analysis

Need Detailed Export Data?

Data Source

IBN SINA SCIENTIFIC BUREAU	IRAQ	$450.7K	22
OMEGA CARE COMPANY	TURKEY	$34.3K	2